Results

Total Results: 447 records

Showing results for "drugs".

161. Blood Pressure Control Evidence and Resources | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/evidencenow/projects/heart-health/evidence/blood-pressure.html
     March 01, 2021 - medications used to treat high blood pressure and includes generic and brand names for all FDA-approved drugs

162. AHRQ's 35th Anniversary | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/cpi/about/35th-anniversary/index.html
     April 01, 2024 - effectiveness, benefits, and harms of different treatment options, generated from research studies that compare drugs

163. Saving Lives and Saving Money: Hospital-Acquired Conditions Update | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/hai/pfp/2014-final.html
     January 01, 2018 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

164. Strategy 6D: Internet Access for Health Information and Advice | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/cahps/quality-improvement/improvement-guide/6-strategies-for-improving/access/strategy6d-internet.html
     April 01, 2023 - Problem Many health care consumers seek information about specific complaints, conditions or diseases, drugs

165. Study Finds Patients Who Self-Test Negative for COVID-19 Not Properly Quarantining | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/news/newsletters/e-newsletter/821.html
     June 01, 2022 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

166. Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-fullreport.pdf
     April 01, 2018 - Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool 1 Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool Section 1. Basic Measure Information 1.A. Measure Name Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool 1.B. Measure Number 0143 1.C. Measure Description …

167. Value Set Export (xls file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085behaviorcoding.xls
     January 01, 2012 - Value Set Export Disclaimer Copyright 2012 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Perfor…

168. 2019 National Healthcare Quality and Disparities Report Data Sources (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-datasources.pdf
     December 01, 2020 - are collected from medical records and include type of provider seen; reason for visit; diagnoses; drugs … characteristics; age at first use, lifetime, past-year, and past-month use of the following substances: illicit drugs

169. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
     February 02, 2012 - methylphenidate (Daytrana [Noven Therapeutics, LLC, Miami, FL]), or OROS methylphenidate (Concerta [Janssen Pharmaceuticals … COMMITTEE Mark Wolraich, MD, Chair – (periodic consultant to Shire, Eli Lilly, Shinogi, and Next Wave Pharmaceuticals … neurologist; AAP Section on Neurology; Child Neurology Society) (Safety Monitoring Board for Best Pharmaceuticals … and other psychotic symptoms associated with the use of attention-deficit/hyper­ activity disorder drugs … Cardiovascular monitor­ ing and stimulant drugs for attention­ deficit/hyperactivity disorder.

170. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
     February 02, 2012 - methylphenidate (Daytrana [Noven Therapeutics, LLC, Miami, FL]), or OROS methylphenidate (Concerta [Janssen Pharmaceuticals … COMMITTEE Mark Wolraich, MD, Chair – (periodic consultant to Shire, Eli Lilly, Shinogi, and Next Wave Pharmaceuticals … (neurologist; AAP Section on Neurology; Child Neurology Society) (Safety Monitoring Board for Best Pharmaceuticals … and other psychotic symptoms associated with the use of attention-deficit/hyper- activity disorder drugs … Cardiovascular monitor- ing and stimulant drugs for attention- deficit/hyperactivity disorder.

171. Use of Multiple Concurrent Antipsychotics in Children (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
     May 01, 2018 - Medicaid from 2002-2007 and saw that both overall psychoactive use and polypharmacy of psychoactive drugs … National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

172. Final Topic Refinement Document - Therapeutic Options for Obesity in the Medicare Population (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/obesity_topic-refinement.pdf
     May 22, 2014 - Final Topic Refinement Document - Therapeutic Options for Obesity in the Medicare Population Final Topic Refinement Document Therapeutic Options for Obesity in the Medicare Population (ID: OBET0913) May 22, 2014 AHRQ Technology Assessment Program Johns Hopkins University Evidence-based Practice Center …

173. PBRN Registry Search | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/ncepcr/communities/pbrn/registry/index.html?page=3
     March 25, 2024 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

174. SHARE Approach Workshop Curriculum | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/health-literacy/professional-training/shared-decision/workshop/mod1-guide.html
     September 01, 2020 - Nonsteroidal anti-inflammatory drugs: NSAIDs (Advil®, Motrin®, Aleve®, and Celebrex®). … Wilson is low income and concerned about the cost of prescription drugs. … Nonsteroidal anti-inflammatory drugs: NSAIDs (Advil®, Motrin®, Aleve®, and Celebrex®).

175. Primary Care Practice Facilitation Curriculum Module 26: An Introduction to Electronic Health Records and Meaningful Use (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-26-ehr-and-mu.pdf
     September 01, 2015 - Primary Care Practice Facilitation Curriculum Module 26: An Introduction to Electronic Health Records and Meaningful Use Primary Care Practice Facilitation Curriculum Module 26: An Introduction to Electronic Health Records and Meaningful Use Agency for Healthcare Research and Quality Advancing Excelle…

176. 6 Tk1 T1-Talking With Residents Checklist Version Final (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T1-Talking_with_Residents_checklist_version_Final.pdf
     October 01, 2016 - Nursing Home Antimicrobial Stewardship Guide Educate & Engage Residents, Family Toolkit To Educate and Engage Residents and Family Members Tool 1. Talking With Residents—short checklist version  What are antibiotics? • Antibiotics are medicines that fight infections caused by bacteria. Antibiotics work by targ…

177. The 10 Questions You Should Know | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/questions/10questions.html
     November 01, 2020 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

178. Study Finds Evidence of Intentional Inappropriate Painkiller Prescribing | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/news/newsletters/e-newsletter/846.html
     January 01, 2023 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

179. New Toolkit Can Improve Post-Surgery Complications and Enhance Patient Recovery | Agency for Healthcare Research and Quality
     www.monahrq.ahrq.gov/news/newsletters/e-newsletter/870.html
     June 01, 2023 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

180. Strategy 4: IDEA Discharge Planning (Tool 3) (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/engagingfamilies/strategy4/Strat4_Tool_3_Physician_HO_508.pdf
     January 01, 2010 - Strategy 4: IDEA Discharge Planning (Tool 3) Guide to Patient and Family Engagement :: 1 Improving Discharge Outcomes with Patients and Families Evidence for engaging patients and families in discharge planning Nearly 20 percent of patients experience an adverse event within 30 days of discharge.1,2 Re…